Prot#WA27788: A Phase II/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients with Systemic Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date4/4/124/4/15

Funding

  • PPD Development (WA27788)
  • Genentech, Inc. (WA27788)